(Updated - August 16, 2022 6:03 AM EDT)

Oppenheimer analyst Brian Nagel downgraded ChromaDex (NASDAQ: CDXC) from Outperform to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE